https://www.foxbusiness.com/markets/merck-to-acquire-prometheus-biosciences-for-10-8b
0
0
32 words
0
Comments
San Diego, California-based Prometheus Biosciences has a drug in development that treats immune diseases including ulcerative colitis and Crohn’s disease.
You are the first to view
Create an account or login to join the discussion